Revelation Biosciences Inc. (REVB) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Revelation Biosciences Inc. (REVB:NASDAQ), powered by AI.

Current Price
$1.00
P/E Ratio
-0.1
Market Cap
618,488
Sector
Healthcare
What is the Revelation Biosciences Inc. stock price forecast?

Revelation Biosciences Inc. is currently trading at $1.00. View real-time AI analysis on Alpha Lenz.

What is Revelation Biosciences Inc. insider trading activity?

View the latest insider trading data for Revelation Biosciences Inc. on Alpha Lenz.

What is Revelation Biosciences Inc.'s P/E ratio?

Revelation Biosciences Inc.'s P/E ratio is -0.1.

Revelation Biosciences Inc.

NASDAQ · REVB
$1.00-0.01(-1.36%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Revelation Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Revelation Biosciences Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -131.4%.

Ask for details

Company Overview

Revelation Biosciences Inc. is a biotechnology company focused on developing diagnostic and therapeutic products to address respiratory and infectious diseases. Their primary function is to innovate in the field of healthcare with novel solutions that can detect and combat prevalent health threats. Notably, Revelation Biosciences is involved in creating point-of-care diagnostic tests that aim to quickly and efficiently identify infections, enabling timely and informed medical decisions. The company also pursues therapeutic development to improve treatment outcomes for patients suffering from respiratory ailments. Within the financial market, Revelation Biosciences contributes to the healthcare and biotech sectors, representing the intersection of technology and medicine to address critical health challenges. With a commitment to research and development, Revelation Biosciences is a key player in improving diagnostic and therapeutic approaches, thus enhancing healthcare delivery and patient care globally.

CEOMr. James M. Rolke
SectorHealthcare
IndustryBiotechnology
Employees8

Company Statistics

FY 2025

Profile

$618.49KMarket Cap
$0.00Revenue
0.00Shares Out
8Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.07P/E
0.07P/B
N/AEV/Sales
1.03EV/EBITDA
-0.07P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-97.93%ROA
-131.38%ROE
-99.65%ROIC

Financial Health

$10.70MCash & Cash Equivalents
$-7.98MNet Debt
30.72%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Revelation Biosciences Inc. (ticker: REVB) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 8 employees. Market cap is $618,488.

The current price is $0.996 with a P/E ratio of -0.07x and P/B of 0.07x.

ROE is -131.38%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Revelation Biosciences Inc. (REVB) Stock Forecast 2026 $1.00 — Price, Financials & Analyst Targets | Alpha Lenz